<DOC>
	<DOCNO>NCT02516150</DOCNO>
	<brief_summary>This study test hypothesis BAC ( blood alcohol content ) 0.1 % significantly alter anti-hypoglycemic effect mico-dose glucagon individual type 1 diabetes .</brief_summary>
	<brief_title>Effect Ethanol Intoxication Anti-Hypoglycemic Action Glucagon</brief_title>
	<detailed_description>This study test hypothesis BAC ( blood alcohol content ) 0.1 % significantly alter anti-hypoglycemic effect mico-dose glucagon individual type 1 diabetes . The study aim quantify effect blood alcohol content anti-hypoglycemic efficacy glucagon use hyperinsulinemic -normoglycemic clamp technique volunteer type 1 diabetes randomize crossover trial .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Age 21 80 year old type 1 diabetes least one year . Diabetes manage use insulin infusion pump use rapidacting insulin insulin aspart ( NovoLog ) , insulin lispro ( Humalog ) , insulin glulisine ( Apidra ) least one week prior enrollment . Alcohol exposure least one occasion last year consist least 4 drink one sit . Unable provide inform consent . Unable comply study procedure . Unable refrain consumption alcohol least 24 hour prior study start . Current participation another diabetesrelated clinical trial , judgment principle investigator , compromise result clamp study safety subject . Pregnancy ( positive urine HCG ) , breast feeding , plan become pregnant immediate future , sexually active without use contraception . Aldehyde dehydrogenase deficiency determine screen questionnaire End stage renal disease dialysis ( hemodialysis peritoneal dialysis ) . History pheochromocytoma ( glucagon report precipitate hypertensive crisis set pheochromocytoma ) . Fractionated metanephrines test patient history increase risk catecholamine secrete tumor : Paroxysms tachycardia , pallor , headache . Personal family history MEN 2A , MEN 2B , neurofibromatosis , von HippelLindau disease , Episodic treatment refractory ( require 4 medication achieve normotension ) hypertension . History adverse reaction glucagon ( include allergy ) besides nausea , vomit , headache . Inadequate venous access determine study nurse physician time screen . Liver failure cirrhosis Hemoglobin &lt; 12 gm/dl . History problem drinking alcoholism , regardless whether active remission . Use benzodiazepines barbiturate opiates central nervous system depressant drug could act synergistically ethanol low level consciousness Any factor , judgment principal investigator , would interfere safe completion study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Type 1 Diabetes</keyword>
	<keyword>Bionic Pancreas</keyword>
	<keyword>Artificial Pancreas</keyword>
	<keyword>Insulin</keyword>
	<keyword>Glucagon</keyword>
	<keyword>Alcohol</keyword>
	<keyword>Alcohol Clamp</keyword>
</DOC>